- Type / Class
- Equity / Common Stock
- Shares outstanding
- 147,079,094
- Total 13F shares
- 127,388,312
- Share change
- -1,524,193
- Total reported value
- $35,598,424,357
- Put/Call ratio
- 99%
- Price per share
- $279.75
- Number of holders
- 1,079
- Value change
- -$380,775,241
- Number of buys
- 464
- Number of sells
- 501
Quarterly Holders Quick Answers
What is CUSIP 09062X103?
CUSIP 09062X103 identifies BIIB - BIOGEN INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 09062X103:
Top shareholders of BIIB - BIOGEN INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
11%
|
15,822,066
|
$3,874,191,000 | — | 31 Dec 2020 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9.1%
|
13,419,599
|
$3,285,921,000 | — | 31 Dec 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.1%
|
11,896,510
|
$2,912,979,000 | — | 31 Dec 2020 | |
| STATE STREET CORP |
13F
|
Company |
4.8%
|
6,992,015
|
$1,712,065,000 | — | 31 Dec 2020 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.9%
|
5,781,973
|
$1,415,774,000 | — | 31 Dec 2020 | |
| Clearbridge Investments, LLC |
13F
|
Company |
2.4%
|
3,598,673
|
$881,171,000 | — | 31 Dec 2020 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.1%
|
3,037,762
|
$743,826,000 | — | 31 Dec 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
2%
|
2,912,021
|
$713,038,000 | — | 31 Dec 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
2,759,498
|
$674,210,000 | — | 31 Dec 2020 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.5%
|
2,200,958
|
$538,926,000 | — | 31 Dec 2020 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.5%
|
2,146,092
|
$525,493,000 | — | 31 Dec 2020 | |
| FMR LLC |
13F
|
Company |
1.3%
|
1,981,867
|
$485,280,000 | — | 31 Dec 2020 | |
| NORGES BANK |
13F
|
Company |
1.3%
|
1,903,653
|
$466,128,000 | — | 31 Dec 2020 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
1,687,298
|
$413,152,000 | — | 31 Dec 2020 | |
| Legal & General Group Plc |
13F
|
Company |
0.84%
|
1,230,474
|
$301,292,000 | — | 31 Dec 2020 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.81%
|
1,190,397
|
$291,480,607 | — | 31 Dec 2020 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.76%
|
1,116,551
|
$273,380,000 | — | 31 Dec 2020 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.69%
|
1,017,422
|
$245,493,000 | — | 31 Dec 2020 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.68%
|
1,001,668
|
$245,268,000 | — | 31 Dec 2020 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.66%
|
976,022
|
$238,989,000 | — | 31 Dec 2020 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.64%
|
938,341
|
$229,762,000 | — | 31 Dec 2020 | |
| PICTET ASSET MANAGEMENT LTD |
13F
|
Company |
0.64%
|
937,627
|
$229,587,000 | — | 31 Dec 2020 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.61%
|
903,310
|
$221,185,000 | — | 31 Dec 2020 | |
| Invesco Ltd. |
13F
|
Company |
0.57%
|
839,970
|
$205,675,000 | — | 31 Dec 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.53%
|
777,503
|
$190,380,000 | — | 31 Dec 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.48%
|
710,402
|
$173,950,000 | — | 31 Dec 2020 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.47%
|
687,793
|
$168,413,000 | — | 31 Dec 2020 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.46%
|
677,896
|
$165,990,000 | — | 31 Dec 2020 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.46%
|
676,727
|
$165,702,000 | — | 31 Dec 2020 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.44%
|
643,890
|
$157,663,000 | — | 31 Dec 2020 | |
| BERKSHIRE HATHAWAY INC |
13F
|
Company |
0.44%
|
643,022
|
$157,450,000 | — | 31 Dec 2020 | |
| Sarissa Capital Management LP |
13F
|
Company |
0.44%
|
643,000
|
$157,444,000 | — | 31 Dec 2020 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.41%
|
602,271
|
$147,472,000 | — | 31 Dec 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.41%
|
598,679
|
$146,592,000 | — | 31 Dec 2020 | |
| Swiss National Bank |
13F
|
Company |
0.41%
|
597,958
|
$146,416,000 | — | 31 Dec 2020 | |
| Bellevue Group AG |
13F
|
Company |
0.38%
|
564,000
|
$138,101,000 | — | 31 Dec 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.37%
|
548,128
|
$134,215,000 | — | 31 Dec 2020 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.37%
|
538,352
|
$131,821,000 | — | 31 Dec 2020 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.36%
|
529,400
|
$129,629,000 | — | 31 Dec 2020 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.35%
|
519,853
|
$127,292,000 | — | 31 Dec 2020 | |
| NORDEA INVESTMENT MANAGEMENT AB |
13F
|
Company |
0.35%
|
517,262
|
$126,657,000 | — | 31 Dec 2020 | |
| VAN ECK ASSOCIATES CORP |
13F
|
Company |
0.35%
|
516,824
|
$126,549,000 | — | 31 Dec 2020 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.34%
|
503,200
|
$123,210,000 | — | 31 Dec 2020 | |
| BARCLAYS PLC |
13F
|
Company |
0.34%
|
500,684
|
$122,598,000 | — | 31 Dec 2020 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.33%
|
489,121
|
$119,766,000 | — | 31 Dec 2020 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.32%
|
473,852
|
$116,028,000 | — | 31 Dec 2020 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.3%
|
448,000
|
$109,697,000 | — | 31 Dec 2020 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.28%
|
413,218
|
$101,181,000 | — | 31 Dec 2020 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
0.27%
|
394,811
|
$96,672,000 | — | 31 Dec 2020 | |
| S.c.a. Candriam |
13F
|
Individual |
0.27%
|
390,870
|
$95,711,000 | — | 31 Dec 2020 |
Institutional Holders of BIOGEN INC. - Common Stock (BIIB) as of Q1 2021
As of 31 Mar 2021,
BIOGEN INC. - Common Stock (BIIB) was held by
1,079 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
127,388,312 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, Clearbridge Investments, LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, Bank of New York Mellon Corp, and NORTHERN TRUST CORP.
This page lists
1,081
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2021 vs Q4 2020 Across Filers
Q4 2020 holders
1,047
Q1 2021 holders
1,079
Holder diff
32
| Investor | Q4 2020 Shares | Q1 2021 Shares | Share Diff | Share Chg % | Q4 2020 Value $ | Q1 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.